AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Choosing the right credit card can help you earn cash back on utility payments. Learn which cards offer the best benefits for your expenses.
26,406 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
A $100,000 investment in Dividend Kings targets $5,400 of passive income each year, reflecting durable payouts amid a...
A retired couple aims to fund $14,500 in monthly expenses from a $2.5 million portfolio. The plan combines three inco...
Investors watched Alphabet slide as news of AI talent exits raised questions about leadership and the pace of AI inve...
Opal Fuels is on investors’ radar for 2026. This guide breaks down the earnings landscape, core drivers, and how to e...
Berkshire Hathaway agreed to acquire Taylor Morrison Home for roughly $8.5 billion, marking a major bet on the U.S. h...
Public firms are embracing bitcoin as a reserve asset to diversify treasury holdings and hedge inflation. This report...
DHT Holdings has benefited from surging tanker rates and a policy of distributing all ordinary net income as dividend...
IonQ posted a 755% YoY jump in Q1 2026 revenue to $64.67 million, but mounting losses and burn risk cast doubt on the...
SpaceX reported a sharp rise in capital expenditures for 2025, with AI infrastructure leading the way. The eye-wateri...
Strategy reveals a potential strategy sell $1.25 billion in Bitcoin to strengthen liquidity and investor confidence a...
A major institutional purchase has put Enviri in the spotlight. This article breaks down what the $43 million buy mea...